Research & Advocacy
Research, Advocacy & Community
Supporting awareness, participation and a stronger amyloidosis community.
Understand the medical tests, the importance of identifying the amyloid protein, and how specialists evaluate affected organs.
Amyloidosis can resemble more common heart, kidney, nerve or digestive conditions. Diagnosis involves identifying amyloid deposits where required, determining the specific amyloid protein and assessing which organs are affected.
Key message: Finding signs of amyloidosis is not the same as identifying its type. AL, ATTR, AA and other forms may require very different care. A specialist combines symptoms, laboratory results, imaging and tissue testing when indicated to establish the diagnosis.
The exact pathway depends on the suspected type and affected organs. These are common stages, not a fixed test sequence for every patient.
Review symptoms, examination findings, medical history and family history.
Look for abnormal proteins and signs of heart, kidney or other organ involvement.
Use appropriate imaging and, in many cases, tissue examination to investigate amyloid.
Identify the amyloid protein and develop a type-specific management plan.
Not every patient needs all of these tests. Your healthcare team selects investigations based on the clinical picture.
These tests help look for evidence of a plasma-cell disorder and assess organ health.
Abnormal blood or urine results alone do not establish a diagnosis of AL amyloidosis.
A clinician may collect a small tissue sample and have it examined for amyloid deposits.
A negative biopsy from one site does not always exclude amyloidosis.
Imaging assesses possible cardiac involvement and supports diagnosis in specific situations.
Certain ATTR heart cases can be diagnosed without heart biopsy only when strict criteria are met, including assessment to exclude AL.
Tests are guided by symptoms and which tissues may be involved.
Organ tests assess involvement but may not independently confirm the amyloid type.
Important: Do not interpret a positive amyloid-related test on its own. A cardiologist, hematologist, nephrologist or other relevant specialist may be needed to interpret the combined findings.
Treatment choices depend on the actual protein deposited, so accurate typing is a core part of specialist evaluation.
When amyloid is found in a tissue sample, the laboratory may use specialized methods to establish the protein responsible.
A biopsy showing amyloid deposits should not automatically be assumed to mean AL amyloidosis.
Genetic testing may be recommended after ATTR is diagnosed, or when hereditary amyloidosis is suspected.
Genetic testing is not a substitute for a complete amyloidosis diagnosis.
About ATTR heart scans: Bone-tracer scintigraphy may establish ATTR cardiac amyloidosis without a biopsy in selected patients when cardiac uptake and the exclusion of an AL-related monoclonal protein disorder meet established criteria. When results are conflicting, further specialist testing or biopsy may be needed.
These answers are general guidance, not a replacement for a personal medical assessment.
No. Blood and urine tests can identify clues such as abnormal light chains or organ changes, but further evaluation is generally needed to confirm amyloidosis and determine its type.
No. Biopsy is commonly used, particularly for AL and many other forms, but some patients with ATTR cardiac amyloidosis may be diagnosed without a heart biopsy under strict clinical and imaging criteria.
Different proteins cause different forms of amyloidosis. Knowing the type is essential because management and treatment strategies differ.
A negative sample may not completely rule out amyloidosis when clinical suspicion remains high. Your specialist may recommend a different sampling site or other investigations.
Depending on symptoms, a hematologist, cardiologist, nephrologist, neurologist or multidisciplinary amyloidosis team may be involved.
If amyloidosis is suspected, discuss suitable investigations and accurate protein typing with your medical team. ASGI promotes awareness and access to educational information.
Medical information notice: This educational page is not a diagnostic tool and does not replace evaluation, testing or medical advice from a qualified healthcare professional.
Medical references: Mayo Clinic — AL diagnosis · Cardiac diagnosis · Amyloid protein typing
